Rifampicin concentration in the tissues of the musculoskeletal system
Kheĭny, I.; Zagorska, T.; Ianik, M.; Melikher, I.
Problemy Tuberkuleza 4: 67-69
1977
ISSN/ISBN: 0032-9533 PMID: 877066 Document Number: 121927
Document emailed within 1 workday
Related Documents
Miyamoto, T. 2018: Homeostasis and Disorder of Musculoskeletal System.Pathogenesis of musculoskeletal diseases and strategies for their treatment Clinical Calcium 28(3): 301-305Tamura, M.; Yamazaki, A.; Tamura, T.; Takano, S.; Yamazaki, M. 1973: The critical concentration of clinical rifampicin resistance for tubercle bacilli and the acquirement pattern of rifampicin resistance of tubercle bacilli on Kirchner's semi-liquid agar media Kekkaku: 48(6): 247-253
Pawlowska, I.; Pniewski, T. 1975: Methods of determination of rifampicin concentration in sputum Gruzlica i Choroby Pluc; Tuberculosis et Pneumonologia 43(11): 969-975
Tsukamura, M. 1972: Critical concentration for definition of rifampicin resistance of tubercle bacilli Kekkaku: 47(5): 113-119
Shpagina, L.N. 2014: Formation and structural features of morbidity in miners with professional pathology of the peripheral nervous system and the musculoskeletal system Gigiena i Sanitariia 3: 37-39
Zeliger, L.R.; Kivman, G.I.; Makarova, R.A.; Chaĭkovskaia, S.M. 1982: Use of agar diffusion method for separate determination of concentration of streptomycin and rifampicin in the blood in the presence of isoniazid Antibiotiki 27(3): 173-176
Mkrtchian, S.V.; Ushkin, V.V. 1971: Study of tuberculostatic activity and blood concentration of new agents--rifampicin and ethambutol--in patients with pulmonary tuberculosis Antibiotiki 16(5): 472-477
Suzuki, N.; Hattori, A.; Hashizume, M. 2016: Development of Four Dimensional Human Model that Enables Deformation of Skin, Organs and Blood Vessel System During Body Movement - Visualizing Movements of the Musculoskeletal System Studies in Health Technology and Informatics 220: 396-402
Woo, J.; Chan, C.; Chan, R.; Cheung, W.; Or, K.; Chan, K. 1995: Correlation between steady-state plasma concentration of antituberculous drugs and age, inclusion of rifampicin in the treatment regimen, adverse drug reactions and other clinical parameters Journal of Medicine 26(5-6): 279-294
Richardson, C.A. 2002: The health of the human skeletal system for weight bearing against gravity: the role of deloading the musculo-skeletal system in the development of musculoskeletal injury Journal of Gravitational Physiology: a Journal of the International Society for Gravitational Physiology 9(1): P7-10
Koralewski, K.; Vidor, K.; Yasko, A. 1993: Malignancies of the musculoskeletal system Seminars in Perioperative Nursing 2(2): 63-69
Yamamoto, F.; Harada, S.; Mitsuyama, T.; Harada, Y.; Kitahara, Y.; Yoshida, M.; Nakanishi, Y. 2004: Concentration of clarithromycin and 14-R-hydroxy-clarithromycin in plasma of patients with Mycobacterium avium complex infection, before and after the addition of rifampicin Japanese Journal of Antibiotics 57(1): 124-133
Angervall, L.; Dahl, I.; Stener, B. 1971: Pseudosarcomatous manifestations in the musculoskeletal system Nordisk Medicin 86(40): 1167
Medoff, G.; Kwan, C.N.; Schlessinger, D.; Kobayashi, G.S. 1973: Potentiation of rifampicin, rifampicin analogs, and tetracycline against animal cells by amphotericin B and polymyxin B Cancer Research 33(6): 1146-1149
Poupon, R.Y.; Meyniel, D.; Petit, J.; Gustot, P.; Darnis, F. 1979: Cholestatic hepatitis during treatment with I.N.H. and rifampicin: arguments in favour of the hepatotoxicity of rifampicin Annales de Medecine Interne 130(6-7): 371-375
Saltoglu, N.; Tasova, Y.; Inal, A.S.; Seki, T.; Aksu, H.S. 2002: Efficacy of rifampicin plus doxycycline versus rifampicin plus quinolone in the treatment of brucellosis Saudi Medical Journal 23(8): 921-924
Rossolini, A.; Cellesi, C.; Debolini, A. 1973: Experimental study of liver damage due to rifampicin and rifampicin-isoniazid combination Il Farmaco; Edizione Pratica 28(6): 345-355
Panchagnula, R.; Singh, I.; Kaur, K.J.; Kaul, C.L. 1999: Bioequivalence study of rifampicin in fixed-dose combination of rifampicin and isoniazid vs. separate formulations Methods and Findings in Experimental and Clinical Pharmacology 21(9): 625-628
Acocella, G.; Segre, G. 1974: Kinetics of rifampicin and desacetyl-rifampicin in plasma, bile, and urine in humans and the effect of repeated administrations Acta Pharmaceutica Suecica 11(6): 657-658
Reimers, D. 1971: Malformations caused by rifampicin? 2 cases of normal fetal development after rifampicin treatment in early pregnancy Münchener Medizinische Wochenschrift 113(50): 1690-1691